Related Experiment Video
Updated: May 23, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
[Kidney injury biomarkers]
Yann Gueguen1, Caroline Rouas, François A Leblond
1PRP-HOM, SRBE, laboratoire de radiotoxicologie expérimentale (LRTOX), Institut de radioprotection et de sureté nucléaire (IRSN), Fontenay-aux-Roses, France. yann.gueguen@irsn.fr
The increasing prevalence of kidney diseases necessitates improved diagnostic tools. Developing novel biomarkers promises faster detection and better treatment strategies for renal failure.
Area of Science:
- Nephrology
- Biomarker Discovery
- Clinical Pathology
Context:
- Rising prevalence of renal diseases in Western societies linked to lifestyle and environmental factors.
- Current diagnostic markers for kidney disease are often slow, lack sensitivity, and primarily assess function over tissue integrity.
- Understanding nephropathology mechanisms is advancing, but clinical management remains challenging.
Purpose:
- To highlight the limitations of current kidney disease biomarkers.
- To emphasize the need for novel biomarkers for rapid diagnosis and improved therapeutic strategies.
- To address the challenges in clinical management of renal failure.
Summary:
- Kidney diseases are increasing due to lifestyle and environmental factors.
- Existing diagnostic markers for kidney disease are insufficient, providing delayed and incomplete information.
- New biomarkers are crucial for early detection, accurate prognosis, and effective treatment of renal failure.
Impact:
- Accelerated diagnosis of kidney diseases.
- Enhanced understanding of renal tissue integrity.
- Optimized clinical strategies for managing renal failure and improving patient outcomes.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Serum Studies: Renal Function Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...